Future Medical Industry Acceleration Initiative Officially Launches, Partners with Fortune 500 Companies in Just Four Steps
“Future Healthcare Industry Acceleration Program”, isJointly initiated by VCBeat, VCBeat Research Institute, and industry support entities including capital institutions, industrial infrastructure service providers, key payers, and research organizations.comprehensive service plan.Aimed at rallying forces within the healthcare industry to support innovation-driven development, it provides next-generation healthcare enterprises with support and assistance in capital matchmaking, resource integration, policy interpretation, and the cultivation of core corporate capabilities, thereby accelerating the growth of future healthcare companies and driving industrial transformation.
This initiative connects innovative healthcare enterprises with supporting service organizations. Centered on the mission of “serving future healthcare companies to accelerate transformation in the medical industry,” and guided by the platform development principles of “high-efficiency matchmaking and standardized processes,” it aims to enhance collaboration efficiency among enterprises and institutions.
The “Future Healthcare Industry Acceleration Program” can be viewed as a service-oriented platform that provides a channel for collaboration between service providers and recipients. For healthcare companies, joining the “Future Healthcare Industry Acceleration Program” grants access to a diverse range of services, including investment and debt financing services, as well as insurance and pharmaceutical company partnership services.
Support service providers can be categorized into six major types: financial, payer, healthcare service provider, foundational technology consulting, promotion, and growth. Enterprises joining the “Future Healthcare Industry Acceleration Program” may select their preferred service categories.
The initiating organizations of the “Future Healthcare Industry Acceleration Program” include VCBeat, Eggshell Research Institute, Legend Capital, Ping An Group, Alibaba Cloud, Fosun Tonghao, Tasly Holding Group, Zhongguancun Technology Leasing Co., Ltd., and China Renaissance. The scientific research advisory institution is the Center for Interdisciplinary Biomedical Studies at the Academy for Advanced Interdisciplinary Studies of Peking University. These ten entities will center on their existing services to provide diverse categories of support to partner enterprises.
VCBeat
VCBeat is a leading content platform in China dedicated to innovation and entrepreneurship in the healthcare sector, boasting the largest team among healthcare new media outlets. Focusing on emerging technologies and the ecological transformations they drive, VCBeat examines future trends through subtle shifts, while observing, documenting, reflecting on, and synthesizing insights to disseminate high-value perspectives on the evolution of business models in future healthcare and the ethical implications underlying new technologies.
As observers, thinkers, and chroniclers of healthcare transformation, we advocate for industry evolution, uncover the logic behind events, and map out the industry landscape, providing reference models, practical case studies, and actionable methodologies to harness the power of innovation.
By leveraging content as the entry point and utilizing connectivity and integrated operations as key drivers, we are gradually evolving into a professional service institution in the future healthcare sector. We have established service units encompassing three major dimensions: new media platforms, enterprise services, and financial services, to comprehensively support industrial transformation and become an innovative ecosystem service platform.
Service Items:
Media Promotion: Promote partners through our owned media platforms, including VCBeat, VB Startup Circle, and the VCBeat WeChat official subscription account, as well as over 100 media outlets. Original content is a core feature of VCBeat.
Investment and Financing: We engage in extensive and in-depth collaborations with internet-focused investment institutions and investors. Through initiatives such as the VB Star Early-Stage Healthcare Startup Support Program, the Xingdong Xiangyi Hui Venture Capital Camp, and the Eggshell Roadshow series (including the Eggshell Roadshow Tree Hole sessions), we help startups understand industry development trends, integrate industrial resources, and provide investment and financing matchmaking services for early-stage projects.
Industrial Resource Integration: VCBeat provides partners with upstream and downstream industrial integration services in the healthcare sector, including but not limited to software and hardware design, supply chain integrators, assembly manufacturers, component suppliers, hospitals and physicians, promotional platforms, sales channels, and government entities.
VCBeat
VCBeat Research Institute is a strategic partner to venture capital and private equity firms in the healthcare industry, providing forward-looking insights into emerging trends to support innovative investment decision-making. We conduct research across five key areas—global capital dynamics, business model innovation, emerging technologies and products, industrial ecosystem evolution, and application penetration trends—from multidimensional perspectives encompassing technology, market, capital, and policy.
Service Items:
Eggshell VIP Membership (Unlimited Access to Research Reports—Trend Analysis, Innovation Cases, and Dynamic Scanning);
Customized Research (Targeted Trend/Specific Project Industry Analysis);
Investor's Internal Reference (Investment Opportunity Assessment and Recommendations);
Consulting Services (Business Model/Innovation Strategy).
Legend Capital
Organization Profile:
“Leveraging capital and management expertise to support and accelerate the growth of Chinese startups.” In 2001, Liu Chuanzhi, President of Legend Holdings, assembled a team led by Zhu Linan to enter the investment sector, committing $35 million from Legend Holdings as the inaugural fund. Thus, Legend Capital was established in April 2001. Legend Capital operated as an independent professional venture capital firm under Legend Holdings. In February 2012, Legend Capital was renamed Joy Capital.
Legend Capital’s core business is positioned in venture capital for start-up stage companies and growth equity for expansion-stage companies.
Currently, Legend Capital manages six U.S. dollar funds and three RMB funds, with total assets under management exceeding RMB 20 billion. The firm focuses on investing in innovative, high-growth companies whose operational entities are based in China or whose markets are closely linked to China.
Legend Capital envisions becoming “the most valuable, respected, and internationally influential investment firm.” By providing capital and management support, it fosters corporate innovation and growth, plays a positive role in advancing industry progress and social development, and seeks to co-create desirable ventures with like-minded partners while sharing in their success.
Service Items: Investment and Financing Services;
Cooperation Process: Submit BP -> Schedule Meeting -> Project Due Diligence -> Investment Decision;
Cooperation Requirements: Provide project materials such as a Business Plan (BP).
Ping An of China
Organization Profile:
Ping An Insurance (Group) Company of China, Ltd. was founded in Shekou, Shenzhen in 1988 as China’s first joint-stock insurance enterprise. It has since grown into one of the leading personal financial lifestyle service groups, integrating three core businesses—insurance, banking, and investment—with parallel development of traditional core finance and internet finance operations.
Ping An of China is committed to becoming an internationally leading provider of personal financial and lifestyle services. Adhering to the philosophy of “technology-led finance, financial services for life,” the company focuses on the two major industries of “big financial assets” and “big healthcare” through two models: “integrated finance + Internet” and “Internet + integrated finance.” Centered around its four core business segments—insurance, banking, asset management, and Internet finance—Ping An creates a brand experience of “professionalism makes life simpler” for its customers. In its Internet business, Ping An continuously enhances its online platforms to meet users’ needs in “healthcare, food, housing, transportation, and entertainment,” offering a variety of services and products that seamlessly integrate financial solutions into online lifestyle services.
Ping An of China ranked 32nd on Forbes’ 2015 “Global 2000” list of the world’s largest public companies; it placed 96th on Fortune magazine’s “Global 500” list, retaining its position as the top non-state-owned enterprise in mainland China. In Interbrand’s “Best Chinese Brands” ranking, Ping An came in sixth, maintaining its status as the leading brand in China’s insurance industry.
Service Offerings: Internet Healthcare + Insurance Fundamental Services, such as Internet Doctors + Insurance, including Individual Physician Medical Malpractice Liability Insurance, Individual Physician Surgical Accident Insurance, Individual Physician Personal Accident Insurance, Doctor-Patient Dispute Insurance, and Specific Infectious Disease Insurance for Medical Personnel; Internet Healthcare + Insurance Specialized Channel Services, including Internet Maternal and Child Care + Insurance (e.g., Maternal and Infant Safety Assurance Insurance), Internet Medical Devices and Equipment + Insurance (e.g., Equipment + Liability Insurance, Equipment + Medical Insurance), Internet Pharmaceutical Companies + Insurance (e.g., Pharmaceuticals + Liability Insurance, Pharmaceutical Companies + Property Insurance), and Internet Hospitals + Insurance (e.g., Hospital + Liability Insurance, Medical + Liability Insurance). Ping An can develop personalized products and services tailored to the specific needs of different internet healthcare platforms.
Cooperation Process: The platform submits insurance service requirements – Ping An evaluates the platform’s capabilities and service feasibility – Ping An develops products or services – System integration between both parties – Implementation of fully online sales (or platform-based purchasing)
Collaboration Requirements:
1. The platform has been successfully operated for more than one year;
2. Annual sales revenue exceeding RMB 10 million;
3. Over 500,000 registered members.
Tasly Holding
Institution Profile:
As a leading enterprise in the pharmaceutical and healthcare industry, Tasly has actively expanded into the broader health sector, adhering to a strategy of driving industrial development through industry incubation and building an incubation platform for innovative and entrepreneurial ventures. The platform focuses on innovative scenarios at key health consumption entry points, such as hospitals, pharmacies, and physical examination centers. Leveraging Tasly Group’s comprehensive support in internationalization, R&D, manufacturing, marketing, and capital, it continuously identifies and fosters the incubation of new innovative and entrepreneurial projects.
After years of continuous business deepening, six major industrial sectors have been established: Health and Wellness Industry, Traditional Chinese Medicine (TCM) Resources Industry, Modern Biopharmaceuticals Industry, Medical Healthcare and Health Management Services, and Children's Education and Health Management Industry.
Service Offerings: Leveraging advantages such as internationalized and advanced production technologies, cross-disciplinary R&D, innovative marketing networks, e-commerce and smart healthcare service systems, centralized procurement and traceability of traditional Chinese medicinal materials, and innovative education initiatives in thermal pain management, we facilitate the incubation of new innovation and entrepreneurship projects. By utilizing a private board advisory mechanism, we bring together leading enterprises from multiple sectors—including pharmaceutical manufacturing, pharmaceutical distribution, chain pharmacies, health examination institutions, health kiosks, and insurance organizations—to converge multi-dimensional innovative resources such as capital, technology, information, and customers, thereby fostering extensive cross-industry linkages and interactions.
Collaboration Process:
1. Information Aggregation: Comprehensive, multi-channel acquisition of project sources;
2. Precise Project Matching and Screening: Leveraging forward-looking insights into industry development to identify precisely matched investment opportunities;
3. Technology and Investment Assessment: Fully leverage Tasly’s multi-tiered pool of qualified experts across various specialized fields, while synergizing with its proprietary funds and partner funds to enhance the investment opportunities for innovative projects;
4. Precision Incubation: Leveraging multi-party industrial resource support for targeted incubation to increase the success rate of innovative project incubation;
5. Fund Synergy: Strengthen the resource integration capabilities of the industrial ecosystem and promote the development of innovative projects through Tasly’s proprietary fund cluster business.
Collaboration Requirements:
1. Key Focus Areas in Emerging Business Sectors Such as Internet Healthcare:
Health insurance-related service providers (including PBM prescription review organizations and third-party administrators (TPAs) for medical insurance management services);
Medical Informatics Projects (Including Patient Health Data and Electronic Medical Records);
Diagnostic entry items (including remote imaging and remote pathology);
Third-party service providers (e.g., online hospitals) associated with the outflow of prescriptions;
Value-added services (such as pharmaceutical care) offered by service-oriented e-commerce platforms;
Post-consultation follow-up, Traditional Chinese Medicine (TCM) wellness, and wearable devices related to chronic disease management;
Patient-facing initiatives and relative population health management (e.g., weight loss, fat reduction, and elderly health care programs);
Medical big data acquisition and processing, health cloud platforms, etc.
2. Key Focus Areas in Technological Innovation:
Molecular Diagnostics: Novel Applications of Next-Generation Sequencing and Supporting Industry Chain Companies (Instruments and Equipment, Reagents and Consumables, Data Storage and Analysis); Emerging Molecular Diagnostic Technologies (From International to Domestic Markets);
Biochemistry and Immunology: High-End Import Substitution with Unique R&D Capabilities
Rapid Testing: A platform-based company driven by both technology and distribution channels; a third-party testing firm with deep channel penetration and accumulated technical expertise, currently in its expansion phase, featuring specialized testing services generating RMB 20–30 million in revenue.
High-End Medical Devices: Cardiovascular Devices, Diabetes Care Devices
New Therapeutic Approaches: Cell Therapy (Stem Cells, CAR-T) and Gene Therapy.
Lenovo Star
Institution Profile:
Legend Star is a wholly-owned subsidiary of Legend Holdings, established in 2008. It pioneered the “deep incubation + angel investment” model in China. Over the past nine years, Legend Star has invested more than RMB 100 million to provide free incubation services to over 700 startups and short-term training to thousands of entrepreneurial companies. Among these, nearly 50 companies have achieved financing valuations exceeding USD 100 million, and a number of publicly listed and well-known enterprises have emerged to date.
Meanwhile, the angel investment fund managed by Legend Star exceeds RMB 1.5 billion in scale. It has invested in more than 150 early-stage startup projects across multiple high-tech sectors, including TMT, healthcare, and intelligent robotics, fostering a cohort of rapidly growing innovative ventures and evolving into China’s largest entrepreneurial ecosystem. Legend Star has built a specialized team for investment and incubation and has been ranked among the Top 10 angel investors in China for consecutive years by CVSource and Zero2IPO.
Service Item: Legend Star Entrepreneurial CEO Training Program;
Participation Process: Follow the Legend Star WeChat Official Account, review the admission criteria, and complete the registration form;
Collaboration Requirements: Startups in the fields of biology and genetic technologies, as well as innovative medical services.
Fosun Tonghao Capital
Organization Profile:
Fosun Tonghao Capital is an early-stage venture capital firm under Fosun Group. Leveraging Fosun Group’s deep industrial resources, it is committed to growing alongside entrepreneurial companies. Tonghao Capital focuses on the healthcare and TMT sectors, specializing in investments at the early and growth stages. Its investment coverage primarily includes seed, angel, Series A, and Series B rounds, with discretionary follow-on investments thereafter. The investment amount per project ranges from several million to tens of millions of RMB.
Service Offerings: Provide funding to innovative enterprises; integrate Fosun’s industrial resources.
Cooperation Process: Innovative enterprises submit business plans and, upon passing Fosun Tonghao’s due diligence, may secure investment. Post-investment, Fosun Tonghao will provide relevant industrial synergies within the Fosun Group and other related services aligned with the enterprise’s development strategy;
Cooperation Requirements: Innovative enterprises in the big health sector at Series B or earlier financing stages.
Alibaba Cloud
Organization Profile:
Alibaba Cloud, the cloud computing brand under Alibaba Group, is a world-class provider of cloud computing technologies and services. It has established R&D centers and operational offices in Hangzhou, Beijing, Silicon Valley, Germany, Japan, and other locations. As China’s leading cloud computing platform, Alibaba Cloud serves customers in more than 200 countries and regions worldwide. Committed to delivering the most secure and reliable computing and data processing capabilities to enterprises, governments, and other organizations, Alibaba Cloud aims to make computing an inclusive technology and public utility, providing a continuous source of new energy for the Data Technology (DT) era of the Internet of Everything.
Cooperative Projects: Cloud hosts (including high-performance computing), cloud storage, CDN, cloud databases, security, big data, video on demand, live video streaming, media transcoding, internet middleware, mobile push notifications, and more.
Cooperation Process:
1. Contact VCBeat to obtain the Alibaba Cloud registration link;
2. After completing account registration, coordinate with Alibaba Cloud architects to plan the solution;
3. Purchase of Alibaba Cloud services and subsequent services.
China Renaissance Zhulu X
Organization Profile:
China Renaissance Zhulu X is a technology-focused investment banking team incubated within China Renaissance. By leveraging primary market transaction data and maintaining high-frequency information exchange with investors, the team gains comprehensive insights into investor preferences. Through professional investment banking services, it aims to better help startups in the new economy sector secure capital and resources. The Zhulu X healthcare team covers more than 400 healthcare investment institutions in the industry, deeply cultivating various sub-sectors of healthcare, and is recognized as the most professional early- to mid-stage financial advisory (FA) firm in the healthcare sector.
Cooperative Projects:
1. High-quality healthcare startup projects can log in to the Zhulu X app to connect for free with over 1,000 investors from more than 400 investment institutions;
2. Attend offline healthcare industry events, engage in private networking with prominent healthcare investors, and participate in discussions on hot topics within the healthcare sector;
3. Facilitate financing services for Zhulu X, including guidance on business plans, matchmaking with healthcare investment institutions, equity structure planning, and corporate brand promotion.
Collaboration Process:
1. Healthcare enterprises with needs for brand promotion and forum activities may contact our marketing team to discuss potential collaboration;
2. For healthcare enterprises seeking financing services, the cooperation process is as follows: Initial meeting → Reaching a cooperation intent → Signing the cooperation agreement → Preparing financing materials, recommending healthcare investment institutions, and assisting in signing the investment agreement → Completing the financing closing.
Cooperation Requirements:
1. Has secured angel financing from institutional investors;
2. The company ranks among the top three in its specific niche sector;
3. The amount of a single financing transaction exceeds RMB 15 million.
Zhongguancun Technology Leasing
Institution Profile:
Established in late 2012, the Company is a state-controlled domestic pilot enterprise for financial leasing, approved by the Ministry of Commerce and the State Administration of Taxation. With a registered capital of RMB 500 million, which is projected to increase to RMB 1 billion by the end of 2016, it is China’s first technology leasing company. Leveraging the Zhongguancun Development Group, a key market-oriented integrated operation platform in the demonstration zone, the Company is committed to “promoting the integration of technology and finance and realizing the dreams of tech entrepreneurs.” It focuses on providing efficient financial services and equipment leasing solutions to technology enterprises, thereby achieving mutually beneficial development for both the technology and financial industries.
Over the four years since its establishment, the company has cumulatively supported nearly 100 clients in the big health industry, with a total leased asset placement amounting to nearly RMB 3 billion. The company has successively received honors such as “Best Financial Leasing Company of 2014” and “Most Innovative Leasing Company of 2015” from the China Financial Institutions Gold List, as well as “Leasing Company of the Year” at the China Financial Leasing Annual Conference. The company plans to serve 100–150 clients in the big health industry between 2017 and 2019, providing total financial support of RMB 3.5–5 billion.
Cooperative Projects: Zhongguancun Leasing’s products for the healthcare industry are categorized into nine types, including sale-and-leaseback, direct leasing, vendor leasing, risk leasing, M&A leasing, venture capital leasing, operating leasing, project leasing, and cluster leasing. These offerings cater to the multi-level, specialized needs of clients in the broader health industry, and can be either individually tailored or combined in structured solutions. They primarily support various sectors such as pharmaceuticals, medical devices, healthcare services, and Internet-plus-healthcare.
Cooperation Process: The cooperation process involves the enterprise submitting an application and preparing relevant documents. Zhongguancun Leasing then initiates the project, conducts due diligence, prepares a project report, and submits it to the Review Committee. Upon approval, the parties proceed with contract signing and fund disbursement. The period from the commencement of due diligence to fund disbursement generally does not exceed 20 working days.
Cooperation Requirements: Enterprises must have products (for pharmaceutical R&D and manufacturing companies, completion of Phase III clinical trials is required in principle), possess core technologies, operate with a mature business model, and generate cash flow. The overall asset-liability ratio shall not exceed 70%, the company must have been established for at least two years, and enterprises that have secured Series A financing will be given priority consideration.
Interdisciplinary Research Center for Biomedical Sciences, Academy for Advanced Interdisciplinary Studies, Peking University
Institution Profile:
The Peking University Interdisciplinary Research Center for Biomedical Sciences is an interdisciplinary research and teaching platform driven by clinical and basic medical questions, composed of researchers from diverse disciplinary backgrounds including clinical medicine, basic medicine, life sciences, physics, chemistry, environmental science, information science, and engineering. In recent years, over one hundred collaborative research papers have been published, many of which appeared in high-impact journals within their respective professional fields.
Researchers from diverse disciplines collaborate to leverage their respective strengths, integrating advanced scientific technologies with cutting-edge clinical medical needs. They have achieved internationally advanced research outcomes in fields such as biomedical materials and tissue engineering, cardiovascular medicine and micro-nano technology applications, plasma medicine, medical imaging technology and healthcare big data analysis and application, and rehabilitation medical engineering, thereby actively promoting the application of frontier scientific technologies in clinical medicine.
Service Items:
1. Open laboratories to innovative medical enterprises, providing them with scientific research capabilities and a hospital-based research environment;
2. Open up scientific research achievements to entrepreneurial teams, providing them with a starting point for entrepreneurship based on technological innovation.
Welcome to the Future Healthcare Industry Initiative
To effectively advance this initiative, we plan to establish the “Future Healthcare Industry Acceleration Consortium” in the subsequent phase. All service-support organizations and innovative enterprises in the healthcare sector are welcome to join.
This plan is hereinafter referred to as FMIA.For collaboration inquiries, please contact VIP@vcbeat.top.